Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP6 | P55212 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | HCAR3 | P49019 | 13/20 | 0.54 |
| ▸ | APEX1 | P27695 | 1/20 | 0.54 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7402680 | 0.89 | CASP6 (0.58) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL7712101 | 0.89 | CASP6 (0.62) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL1483517 | 0.88 | CASP6 (0.66) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL30481076 | 0.88 | CASP6 (0.66) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL2292095 | 0.87 | CASP6 (0.64) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL27411911 | 0.85 | CASP6 (0.62) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL6180268 | 0.85 | HCAR3 (0.64) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL5913447 | 0.85 | CASP6 (0.62) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL6341472 | 0.85 | CASP6 (0.66) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL20757 | 0.85 | PDK1 (0.68) | CASP6TSHRLMNAHCAR3APEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9359396-B2 | Material for supported synthesis and method for growing oligonucleotides or peptides | UNIVERSITE CLAUDE BERNARD LYON I (FR) | 2016-06-07 | — | — | US | claimed |
| US-20140135478-A1 | MATERIAL FOR SUPPORTED SYNTHESIS AND METHOD FOR GROWING OLIGONUCLEOTIDES OR PEPTIDES | UNIVERSITE CLAUDE BERNARD LYON I (FR) | 2014-05-15 | — | — | US | claimed |
| US-12304884-B2 | Photo-cleavable surfactants | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-05-20 | — | — | US | disclosed |
| US-20230139837-A1 | Photo-Cleavable Surfactants | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2023-05-04 | — | — | US | disclosed |
| US-11567085-B2 | Photo-cleavable surfactants | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2023-01-31 | — | — | US | disclosed |
| US-20210253519-A1 | Photo-Cleavable Surfactants | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2021-08-19 | — | — | US | disclosed |
| US-9359396-B2 | Material for supported synthesis and method for growing oligonucleotides or peptides | UNIVERSITE CLAUDE BERNARD LYON I (FR) | 2016-06-07 | — | — | US | disclosed |
| US-20140135478-A1 | MATERIAL FOR SUPPORTED SYNTHESIS AND METHOD FOR GROWING OLIGONUCLEOTIDES OR PEPTIDES | UNIVERSITE CLAUDE BERNARD LYON I (FR) | 2014-05-15 | — | — | US | disclosed |
| US-6046306-A | SOLID PHASE SYNTHESIS OF PEPTIDE NUCLEIC ACIDS ALLOWING OLIGOMER TO BE CLEAVED OFF FROM THE SOLID SUPPORT UNDER THE ALKALINE CONDITIONS CONVENTIONALLY USED FOR OLIGONUCLEOTIDES | HOECHST AKTIENGESELLSCHAFT (DE) | 2000-04-04 | — | — | US | disclosed |
| EP-0672700-B1 | PNA-synthesis using an aminoprotecting group which is labile against weak acids | HOECHST AG (DE) | 1999-06-02 | — | — | EP | disclosed |
| CN-1215404-A | Non-dendritic backbone piptide carrier | PEPRESEACH A S (DK) | 1999-04-28 | — | — | CN | disclosed |
| EP-0896582-A1 | NON-DENDRITIC BACKBONE PEPTIDE CARRIER | Pepresearch A/S (DK) | 1999-02-17 | — | — | EP | disclosed |
| WO-1997038011-A1 | NON-DENDRITIC BACKBONE PEPTIDE CARRIER | PEPRESEARCH A/S (DK) | 1997-10-16 | — | — | WO | disclosed |
| US-5601992-A | DETECTING INTERACTION BETWEEN PEPTIDE AND TARGET BY PLACING TARGET INTO CONTAINER, OVERLAYING WITH SUBSTRATE, APPLYING BEADS TO SUBSTRATE, EACH BEAD HAVING ASSOCIATED THEREWITH COPIES OF A SINGLE PEPTIDE, ALLOWING DIFFUSION, REACTION | BUNSEN RUSH LABORATORIES, INC. (US) | 1997-02-11 | — | — | US | disclosed |
| EP-0672700-A1 | PNA-synthesis using an aminoprotecting group which is labile against weak acids | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-09-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12304884-B2 | Photo-cleavable surfactants | PTMS, PRSS1, SRMS | CASP6 584/4885TSHR 2734/4885LMNA 1320/4885 |
| US-11567085-B2 | Photo-cleavable surfactants | PTMS, PRSS1, SRMS | CASP6 584/4885TSHR 2734/4885LMNA 1320/4885 |
| US-20230139837-A1 | Photo-Cleavable Surfactants | PTMS, PRSS1, SRMS | CASP6 584/4885TSHR 2734/4885LMNA 1320/4885 |
| US-20210253519-A1 | Photo-Cleavable Surfactants | PTMS, PRSS1, TMPRSS4 | CASP6 546/4885TSHR 2036/4885LMNA 1173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.